The inhibitory effects of quercetin on obesity and obesity-induced inflammation by regulation of MAPK signaling

Journal of Nutritional Biochemistry

Volumn 26, Issue 11, 2015, Pages 1308-1316

  Seo, Min Jung ^a   Lee, Yeon Joo ^a   Hwang, Ji Hyun ^a   Kim, Kui Jin ^b   Lee, Boo Yong ^a  

^a CHA University   (South Korea)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adipogenesis; MAPK signaling; Obesity; Obesity induced inflammation; Quercetin

Indexed keywords

ALBUMIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; DIACYLGLYCEROL ACYLTRANSFERASE 1; FATTY ACID BINDING PROTEIN 4; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE ENZYME THETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P70; QUERCETIN; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; NITRIC OXIDE; TRANSCRIPTION FACTOR;

3T3 CELL LINE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DIET INDUCED OBESITY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SYNTHESIS; INFLAMMATION; INSULIN RESISTANCE; LIPID STORAGE; LIPOGENESIS; MACROPHAGE; MOUSE; NONHUMAN; OBESITY INDUCED INFLAMMATION; PHYSIOLOGICAL PROCESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ZEBRA FISH; 3T3-L1 CELL LINE; ADVERSE EFFECTS; ANIMAL; CELL SURVIVAL; COMPLICATION; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIPID DIET; LIPID METABOLISM; MALE; MAPK SIGNALING; METABOLISM; OBESITY;

3T3-L1 CELLS; ADIPOGENESIS; ANIMALS; CELL SURVIVAL; CYTOKINES; DIET, HIGH-FAT; INFLAMMATION; LIPID METABOLISM; LIPOGENESIS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED ICR; NITRIC OXIDE; OBESITY; QUERCETIN; TRANSCRIPTION FACTORS; ZEBRAFISH;

EID: 84946487179     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.06.005     Document Type: Article

References (55)

1. Lin T.Y., Liu Y.C., Jheng J.R., Tsai H.P., Jan J.T., Wong W.R., et al. Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am J Chin Med 2009, 37:143-158.
2. Stewart L.K., Soileau J.L., Ribnicky D., Wang Z.Q., Raskin I., Poulev A., et al. Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metab Clin Exp 2008, 57:S39-S46.
3. Ramos F.A., Takaishi Y., Shirotori M., Kawaguchi Y., Tsuchiya K., Shibata H., et al. Antibacterial and antioxidant activities of quercetin oxidation products from yellow onion (Allium cepa) skin. J Agric Food Chem 2006, 54:3551-3557.
4. Davis J.M., Murphy E.A., Carmichael M.D., Davis B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 2009, 296:R1071-R1077.
5. Russo M., Spagnuolo C., Tedesco I., Bilotto S., Russo G.L. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 2012, 83:6-15.
6. Spiegelman B.M., Choy L., Hotamisligil G.S., Graves R.A., Tontonoz P. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem 1993, 268:6823-6826.
7. de Ferranti S., Mozaffarian D. The perfect storm; obesity, adipocyte dysfunction and metabolic consequences. Clin Chem 2008, 54:945-955.
8. Lowe C.E., O'Rahilly S., Rochford J.J. Adipogenesis at a glance. J Cell Sci 2011, 124:2681-2686.
9. Seo M.J., Choi H.S., Jeon H.J., Woo M.S., Lee B.Y. Baicalein inhibits lipid accumulation by regulating early adipogenesis and m-TOR signaling. Food Chem Toxicol 2014, 67:57-64.
10. Attie A.D., Scherer P.E. Adipocyte metabolism and obesity. J Lipid Res 2009, 50:S395-S399.
11. Ma X.M., Blenis J. Molecular mechanisms of m-TOR-mediated translational control. Nat Rev Mol Cell Biol 2009, 10:307-318.
12. Kim J.E., Chen J. Regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 2004, 53:2748-2756.
13. Yeh W.C., Bierer B.E., McKnight S.L. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci U S A 1995, 92:11086-11090.
14. Bell A., Grunder L., Sorisky A. Rapamycin inhibits human adipocyte differentiation in primary culture. Obes Res 2000, 8:249-254.
15. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001, 81:807-869.
16. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001, 22:153-183.
17. Pagano E., Coso O., Calvo J.C. Downmodulation of erbB2 activity is necessary but not enough in the differentiation of 3T3-L1 preadipocytes. J Cell Biochem 2008, 104:274-285.
18. Prusty D., Park B.H., Davis K.E., Farmer S.R. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 2002, 277:6226-46232.
19. Tang Q.Q., Grønborg M., Huang H., Kim J.W., Otto T.C., Pandey A., et al. Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc Natl Acad Sci U S A 2005, 102:9766-9771.
20. Bost F., Aouadi M., Caron L., Binétruy B. The role of MAPKs in adipocyte differentiation and obesity. Biochimie 2005, 87:51-56.
21. Hirosumi J., Tuncman G., Chang L., Görgün C.Z., Uysal K.T., Maeda K., et al. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
22. Jaeschke A., Czech M.P., Davis R.J. An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue. Genes Dev 2004, 18:1976-1980.
23. Patel N.G., Holder J.C., Smith S.A., Kumar S., Eggo M.C. Differential regulation of lipogenesis and leptin production by independent signaling pathways and rosiglitazone during human adipocyte differentiation. Diabetes 2003, 52:43-50.
24. Aouadi M., Jager J., Laurent K., Gonzalez T., Cormont M., Binétruy B., et al. p38MAP Kinase activity is required for human primary adipocyte differentiation. FEBS Lett 2007, 581:5591-5596.
25. Aggarwal B.B. Signalling pathways of the TNF-α super family: a double-edged sword. Nat Rev Immunol 2003, 9:745-756.
26. Tak P.P., Firestein G.S. NF-κB: a key role in inflammatory diseases. J Clin Invest 2001, 107:7-11.
27. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy - from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 1754, 2005:253-262.
28. Manthey C.L., Wang S.W., Kinney S.D., Yao Z. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol 1998, 64:409-417.
29. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
30. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
31. Skurk T., Alberti-Huber C., Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007, 92:1023-1033.
32. Farber S.A., Pack M., Ho S.Y., Johnson I.D., Wagner D.S., Dosch R., et al. Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science 2001, 292:1385-1388.
33. Patton E.E., Zon L.I. The art and design of genetic screens: zebrafish. Nat Rev Genet 2001, 2:956-966.
34. Flynn E.J., Trent C.M., Rawls J.F. Ontogeny and nutritional control of adipogenesis in zebrafish (Danio rerio). J Lipid Res 2009, 50:1641-1652.
35. Lee O.H., Kwon Y.I., Apostolidis E., Shetty K., Kim Y.C. Rhodiolainduced inhibition of adipogenesis involves antioxidant enzyme response associated with pentose phosphate pathway. Phytother Res 2011, 25:106-115.
36. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., et al. m-TOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
37. Fingar D.C., Richardson C.J., Tee A.R., Cheatham L., Tsou C., Blenis J. m-TOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 2004, 24:200-216.
38. Farrar C., Houser C.R., Clarke S. Activation of the PI3K/Akt signal transduction pathway and increased levels of insulin receptor in protein repair-deficient mice. Aging Cell 2005, 4:1-12.
39. Ouchi N., Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007, 380:24-30.
40. Shimabukuro M., Ohneda M., Lee Y., Unger R. Role of nitric oxide in obesity-induced β cell disease. J Clin Invest 1997, 100:290-295.
41. von Knethen A., Callsen D., Brüne B. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell 1999, 10:361-372.
42. Kyriakis J.M. Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. Gene Expr 1999, 7:217-231.
43. Aupperle K.R., Bennett B.L., Boyle D.L., Tak P.P., Manning A.M., Firestein G.S. NF-kB regulation by IkB kinase in primary fibroblast-like synoviocytes. J Immunol 1999, 163:427-433.
44. Kurosawa M., Numazawa S., Tani Y., Yoshida T. ERK signaling mediates the induction of inflammatory cytokines by bufalin in human monocytic cells. Am J Physiol Cell Physiol 2000, 278:C500-C508.
45. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
46. Ip Y.T., Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 1998, 10:205-219.
47. Zarubin T., Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005, 15:11-18.
48. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics 1997, 46:120-128.
49. Kim C.Y., Le T.T., Chen C., Cheng J.X., Kim K.H. Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion. J Nutr Biochem 2011, 22:910-920.
50. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
51. Coleman R.A., Mashek D.G. Mammalian triacylglycerol metabolism: synthesis, lipolysis and signaling. Chem Rev 2011, 111:6359-6386.
52. Zhang P., O'Loughlin L., Brindley D.N., Reue K. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis. J Lipid Res 2008, 49:1519-1528.
53. Bou K.M., Sundaram M., Zhang H.Y., Links P.H., Raven J.F., Manmontri B. The level and compartmentalization of phosphatidate phosphatase-1 (lipin-1) control the assembly and secretion of hepatic VLDL. J Lipid Res 2009, 50:47-58.
54. Kim H.E., Bae E., Jeong D.Y., Kim M.J., Jin W.J., Park S.W. Lipin1 regulates PPARγ transcriptional activity. Biochem J 2013, 453:49-60.
55. Laplante M., Sabatini D.M. An emerging role of mTOR in lipid biosynthesis. Curr Biol 2009, 19:R1046-R1052.